Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/ijerph18094640 http://scihub22266oqcxt.onion/10.3390/ijerph18094640 33925518!8123865!33925518     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Environ+Res+Public+Health 2021 ; 18 (9): ä Nephropedia Template TP {{tp|p=33925518|t=2021. Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2 |pdf=|usr=}}{{33925518}} gab.com Text Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2 JO: Int J Environ Res Public Health http://www.kidney.de/pget.php?&tw=1&pmid=33925518 #FOAvip SARS-CoV-2 continues to widely circulate in populations globally. Underdetection is acknowledged and is problematic when attempting to capture the true prevalence. Seroprevalence studies, where blood samples from a population sample are tested for SARS-CoV-2 antibodies that react to the SARS-CoV-2 virus, are a common method for estimating the proportion of people previously infected with the virus in a given population. However, obtaining reliable estimates from seroprevalence studies is challenging for a number of reasons, and the uncertainty in the results is often overlooked by scientists, policy makers, and the media. This paper reviews the methodological issues that arise in designing these studies, and the main sources of uncertainty that affect the results. We discuss the choice of study population, recruitment of subjects, uncertainty surrounding the accuracy of antibody tests, and the relationship between antibodies and infection over time. Understanding these issues can help the reader to interpret and critically evaluate the results of seroprevalence studies. Twit Text FOAVip Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2 ????Int J Environ Res Public Health http://www.kidney.de/pget.php?&tw=1&pmid=33925518 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33925518 #FOAvip English Wikipedia <ref>{{Cite pmid|33925518}}</ref> Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2 #MMPMID33925518 McConnell D; Hickey C; Bargary N; Trela-Larsen L; Walsh C; Barry M; Adams R Int J Environ Res Public Health 2021[Apr]; 18 (9): ä PMID33925518show ga SARS-CoV-2 continues to widely circulate in populations globally. Underdetection is acknowledged and is problematic when attempting to capture the true prevalence. Seroprevalence studies, where blood samples from a population sample are tested for SARS-CoV-2 antibodies that react to the SARS-CoV-2 virus, are a common method for estimating the proportion of people previously infected with the virus in a given population. However, obtaining reliable estimates from seroprevalence studies is challenging for a number of reasons, and the uncertainty in the results is often overlooked by scientists, policy makers, and the media. This paper reviews the methodological issues that arise in designing these studies, and the main sources of uncertainty that affect the results. We discuss the choice of study population, recruitment of subjects, uncertainty surrounding the accuracy of antibody tests, and the relationship between antibodies and infection over time. Understanding these issues can help the reader to interpret and critically evaluate the results of seroprevalence studies. |*COVID-19[MESH] |*SARS-CoV-2[MESH] |Antibodies, Viral[MESH] |Humans[MESH] |Prevalence[MESH] |Seroepidemiologic Studies[MESH]Understanding the Challenges and Uncertainties of Seroprevalence Studi(epmc).pdf DeepDyve Pubget Overpricing